Described herein are opioid prodrugs, methods of making opioid prodrugs, formulations comprising opioid prodrugs, and methods of using opioid prodrugs. One embodiment described herein relates to the transdermal administration of a buprenorphine prodrug in an abuse-resistant formulation for treating and preventing diseases and/or disorders.

 
Web www.patentalert.com

< Aqueous sanitizers, disinfectants, and/or sterilants with low peroxygen content

> Water-based process for the preparation of polymer-clay nanocomposites

> Water base ink for ink-jet recording

~ 00509